National Cancer Institute Seeks Pharmaceutical Partner for PEGylation of Cyanovirin-N for Infectious Disease Treatment

Summary

The National Cancer Institute is seeking a pharmaceutical or biotechnology company to collaborate on the development of PEG-CV-N conjugates for non-retroviral treatment of infectious diseases, such as influenza viruses.